» Articles » PMID: 23671463

An Investigation into Drug-related Problems Identifiable by Commercial Medication Review Software

Overview
Journal Australas Med J
Specialty General Medicine
Date 2013 May 15
PMID 23671463
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Accredited pharmacists conduct home medicines reviews (HMRs) to detect and resolve potential drug-related problems (DRPs). A commercial expert system, Medscope Review Mentor (MRM), has been developed to assist pharmacists in the detection and resolution of potential DRPs.

Aims: This study compares types of DRPs identified with the commercial system which uses multiple classification ripple down rules (MCRDR) with the findings of pharmacists.

Method: HMR data from 570 reviews collected from accredited pharmacists was entered into MRM and the DRPs were identified. A list of themes describing the main concept of each DRP identified by MRM was developed to allow comparison with pharmacists. Theme types, frequencies, similarity and dissimilarity were explored.

Results: The expert system was capable of detecting a wide range of potential DRPs: 2854 themes; compared to pharmacists: 1680 themes. The system identified the same problems as pharmacists in many patient cases. Ninety of 119 types of themes identifiable by pharmacists were also identifiable by software. MRM could identify the same problems in the same patients as pharmacists for 389 problems, resulting in a low overlap of similarity with an averaged Jaccard Index of 0.09.

Conclusion: MRM found significantly more potential DRPs than pharmacists. MRM identified a wide scope of DRPs approaching the range of DRPs that were identified by pharmacists. Differences may be associated with system consistency and perhaps human oversight or human selective prioritisation. DRPs identified by the system were still considered relevant even though the system identified a larger number of problems.

Citing Articles

Impact of a Digital Tool on Pharmacy Students' Ability to Perform Medication Reviews: A Randomized Controlled Trial.

Dabidian A, Obarcanin E, Ali Sherazi B, Schlottau S, Schwender H, Laeer S Healthcare (Basel). 2023; 11(13).

PMID: 37444802 PMC: 10341599. DOI: 10.3390/healthcare11131968.


A user-centered evaluation of medication therapy management alerts for community pharmacists: Recommendations to improve usability and usefulness.

Snyder M, Adeoye-Olatunde O, Gernant S, Diiulio J, Jaynes H, Doucette W Res Social Adm Pharm. 2020; 17(8):1433-1443.

PMID: 33250363 PMC: 9178508. DOI: 10.1016/j.sapharm.2020.10.015.


Artificial intelligence in health - the three big challenges.

Khanna S, Sattar A, Hansen D Australas Med J. 2013; 6(5):315-7.

PMID: 23745154 PMC: 3674424. DOI: 10.4066/AMJ.2013.1758.

References
1.
Bindoff I, Tenni P, Peterson G, Kang B, Jackson S . Development of an intelligent decision support system for medication review. J Clin Pharm Ther. 2007; 32(1):81-8. DOI: 10.1111/j.1365-2710.2007.00801.x. View

2.
Martins S, Lai S, Tu S, Shankar R, Hastings S, Hoffman B . Offline testing of the ATHENA Hypertension decision support system knowledge base to improve the accuracy of recommendations. AMIA Annu Symp Proc. 2007; :539-43. PMC: 1839611. View

3.
Williams M, Peterson G, Tenni P, Bindoff I, Stafford A . DOCUMENT: a system for classifying drug-related problems in community pharmacy. Int J Clin Pharm. 2011; 34(1):43-52. DOI: 10.1007/s11096-011-9583-1. View

4.
Hughes J, Lockhart J, Joyce A . Do calcium antagonists contribute to gastro-oesophageal reflux disease and concomitant noncardiac chest pain?. Br J Clin Pharmacol. 2007; 64(1):83-9. PMC: 2000612. DOI: 10.1111/j.1365-2125.2007.02851.x. View

5.
Gallagher P, Ryan C, Byrne S, Kennedy J, OMahony D . STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008; 46(2):72-83. DOI: 10.5414/cpp46072. View